Skip to main content
. 2012 May 18;17(7):900–909. doi: 10.1634/theoncologist.2011-0442

Table 1.

Analysis of events in the intent-to-treat population

graphic file with name onc00712-1072-t01.jpg

aFirst event defined according to the disease-free survival criteria (i.e., local relapse, regional relapse, distant relapse, contralateral breast cancer, death of any cause).

Abbreviations: FEC, fluorouracil, epirubicin, and cyclophosphamide; FEC-D, fluorouracil, epirubicin, and cyclophosphamide followed by docetaxel.